WARING FEDERAL STRATEGIES for AUTM
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY '26 funding for major research agencies (NIH, NSF, etc.)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL WARING | — |
Copyright/Patent/Trademark CPT
S. 708 and H.R. 1534 -- RESTORE Patent Rights Act of 2025 -- issues related to injunctions for patent infringement S. 1546 and H.R. 3152 -- Patent Eligibility Restoration Act -- related to clarifications of Section 101 of patent law S. 1553 and H.R. 3160 -- PREVAIL Act (Promoting and Respecting Economically Vital American Innovation Leadership Act -- related to reforms of the Patent Trials and Appeals Board at the US Patent and Trademark Office
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL WARING | — |
Science/Technology SCI
NOT- OD - 25 - 068 --- Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL WARING | — |
Small Business SMB
S. 853 -- INNOVATE Act -- related to re-authorization of the Small Business Innovation Research and Small Business Technology Transfer programs Discussions re: House versions of similar Senate SBIR/STTR legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL WARING | — |
Taxation/Internal Revenue Code TAX
H.R. 1 -- to provide for reconciliation pursuant to title II of H. Con. Res. 14 -- provisions related to taxing litigation funding for patent cases as well as taxability of university licensing revenues -- also provisions related to Section 174 of IRS law related to taxes on Small Business Innovation Research grants
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL WARING | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.